What does four‑factor prothrombin complex concentrate (4‑factor PCC) contain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Composition of 4-Factor Prothrombin Complex Concentrate

4-factor PCC contains therapeutic amounts of four vitamin K-dependent coagulation factors: Factor II (prothrombin), Factor VII, Factor IX, and Factor X, plus the anticoagulant proteins C and S. 1, 2, 3

Core Components

  • The four clotting factors (II, VII, IX, X) are obtained from pooled human plasma and concentrated to approximately 25 times the levels found in fresh frozen plasma per unit volume 2

  • Protein C and Protein S are included as natural anticoagulant proteins to help balance the thrombotic risk 1, 2, 3

  • Small amounts of heparin are added to many formulations to reduce the risk of thrombosis 1, 2

  • Antithrombin is present in some formulations as an additional safety measure against thrombotic complications 1, 2

Product Characteristics

  • The product undergoes viral inactivation and pathogen reduction processes during manufacturing, making it free of viral contaminants 2, 4

  • It is stored as a lyophilized (freeze-dried) powder at room temperature, allowing for rapid reconstitution at bedside in 20-30 minutes 2, 5

  • No ABO blood group compatibility testing is required, unlike fresh frozen plasma 2

  • The product is dosed based on Factor IX content, with actual potency ranging from 20-32 Factor IX units/mL after reconstitution 3

What Distinguishes 4-Factor from 3-Factor PCC

  • 4-factor PCCs contain adequate therapeutic levels of Factor VII, while 3-factor PCCs have low or negligible Factor VII content 1, 2, 5

  • This distinction is clinically important because Factor VII has the shortest half-life (approximately 6 hours) of the vitamin K-dependent factors and is critical for rapid INR reversal 2

Important Clinical Context

  • The half-lives of the contained factors vary significantly: Factor VII (6 hours), Factor IX (20 hours), Factor X (30 hours), and Factor II (60 hours) 2

  • Vitamin K must always be co-administered with 4-factor PCC because the short half-life of Factor VII means the reversal effect will wear off within 12-24 hours, while warfarin's anticoagulant effect persists much longer 1, 2

  • Commercial products may vary slightly in their exact composition of coagulation factors, inhibitors, and the presence/amount of heparin and antithrombin 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Reversal of Anticoagulation with 4-Factor Prothrombin Complex Concentrate

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Is prothrombin complex concentrate (PCC) a blood component or a blood product?
What evidence supports using a four‑factor prothrombin complex concentrate (factors II, VII, IX, and X) instead of fresh‑frozen plasma for rapid reversal of vitamin‑K antagonist anticoagulation in urgent bleeding or before emergency surgery?
In a patient undergoing massive transfusion, can injectable prothrombin complex concentrate be administered after pausing the blood transfusion, and what criteria dictate when to restart the transfusion?
Can a Jehovah's Witness receive four-factor prothrombin complex concentrate (4F-PCC)?
What is 4-factor Prothrombin Complex Concentrate (PCC)?
Which topical eye drop regimen should be used to treat postoperative or non‑infectious anterior segment inflammation in an adult without glaucoma, uncontrolled diabetes, or active ocular infection?
How should I evaluate and manage iron‑deficiency anemia in a 56‑year‑old man with ferritin 12 ng/mL, serum iron 32 µg/dL, total iron‑binding capacity 389 µg/dL, and transferrin saturation 8%?
I’m allergic to sulfonamides and have already completed azithromycin (Z‑Pak) and amoxicillin‑clavulanate (Augmentin) for an ear infection; what is the next appropriate step in management?
What is the recommended evaluation and management of a supracondylar humerus fracture in a child (age 5‑10)?
What is the recommended treatment for mild wrist osteopenia (T-score –1.0 to –2.5)?
What is the recommended management of norovirus infection, including fluid replacement, antiemetic use, and infection‑control precautions?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.